J&J units face subpoenas

Johnson & Johnson (J&J; New Brunswick, New Jersey) reported that it has received separate subpoenas from the U.S. Attorney's Offices in Philadelphia, Boston and in San Francisco.

The subpoenas relate to investigations by those three offices previously disclosed in SEC filings and directed, respectively, to sales and marketing of Risperdal by Janssen (Titusville, New Jersey), Topamax by Ortho-McNeil Pharmaceutical (Raritan, New Jersey) and Natrecor by Scios (Fremont, California) — each a J&J subsidiary

The subpoenas request information regarding J&J's corporate supervision and oversight of these three subsidiaries, including their sales and marketing of these drugs.

J&J said it will cooperate in responding to these requests.